Who invested in SAGE Therapeutics?
SAGE Therapeutics's investors include ARCH Venture Partners, Third Rock Ventures, OrbiMed, Foresite Capital and EcoR1 Capital.
United States · Funded startup
4 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$743Mraised across 4 rounds since 2011, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $650M sold, first sale Dec 2020
From a historical funding recordSEC filing: $38M sold, first sale Mar 2014
Reported by 4-traders.comSEC filing: $10M sold, first sale Jan 2014
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
SAGE Therapeutics's investors include ARCH Venture Partners, Third Rock Ventures, OrbiMed, Foresite Capital and EcoR1 Capital.
SAGE Therapeutics has raised $743M across 4 rounds since 2011.
SAGE Therapeutics's most recent round was an Undisclosed round of $650M in Nov 2020.
Its most recent round, $650M in Nov 2020, is also its largest on record.
SAGE Therapeutics's first round on record, in Oct 2011, was backed by Third Rock Ventures.
SAGE Therapeutics's latest named round is an Undisclosed round, in Nov 2020.
SAGE Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.